|
x |
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
|
o |
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Delaware
|
|
06-0853042
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer Identification Number)
|
3
Great Pasture Road
|
||
Danbury,
Connecticut
|
06813
|
|
(Address
of Principal Executive Offices)
|
Zip
Code
|
|
Page
|
||
PART I. FINANCIAL INFORMATION
|
|
||
Item 1.
|
|
Consolidated
Financial Statements (unaudited)
|
|
|
|
Consolidated
Balance Sheets as of July 31, 2008 and October 31, 2007
|
3
|
|
|
Consolidated
Statements of Operations for the three months ended July 31, 2008
and
2007
|
4
|
Consolidated
Statements of Operations for the nine months ended July 31, 2008
and
2007
|
5
|
||
Consolidated
Statements of Cash Flows for the nine months ended July 31, 2008
and
2007
|
6
|
||
|
|
Notes
to Consolidated Financial Statements
|
7
|
Item 2.
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
|
18
|
Item 3.
|
|
Quantitative
and Qualitative Disclosures about Market Risk
|
34
|
Item 4.
|
|
Controls
and Procedures
|
35
|
PART II. OTHER INFORMATION
|
|||
Item 6.
|
|
Exhibits
|
36
|
|
|
Signature
|
37
|
July 31,
2008
(Unaudited)
|
October 31,
2007
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
50,920
|
$
|
92,997
|
|||
Investments:
U.S. treasury securities
|
26,746
|
60,634
|
|||||
Accounts
receivable, net of allowance for doubtful accounts of $16 and $63,
respectively
|
19,780
|
10,063
|
|||||
Inventories,
net
|
27,116
|
29,581
|
|||||
Other
current assets
|
8,895
|
7,730
|
|||||
Total
current assets
|
133,457
|
201,005
|
|||||
Property,
plant and equipment, net
|
38,761
|
39,612
|
|||||
Investments:
U.S. treasury securities
|
26,725
|
—
|
|||||
Investment
and loan to affiliate
|
10,939
|
12,216
|
|||||
Other
assets, net
|
485
|
355
|
|||||
Total
assets
|
$
|
210,367
|
$
|
253,188
|
|||
|
|||||||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Current
portion of long-term debt and other liabilities
|
$
|
776
|
$
|
924
|
|||
Accounts
payable
|
16,389
|
9,516
|
|||||
Accounts
payable due to affiliate
|
911
|
2,881
|
|||||
Accrued
liabilities
|
8,948
|
8,511
|
|||||
Deferred
license fee income
|
600
|
—
|
|||||
Deferred
revenue and customer deposits
|
33,959
|
20,486
|
|||||
Total
current liabilities
|
61,583
|
42,318
|
|||||
Long-term
deferred revenue
|
3,084
|
4,401
|
|||||
Long-term
debt and other liabilities
|
3,116
|
613
|
|||||
Total
liabilities
|
67,783
|
47,332
|
|||||
Redeemable
minority interest
|
12,835
|
11,884
|
|||||
Redeemable
preferred stock ($0.01 par value, liquidation preference of $64,120
at
July 31, 2008 and October 31, 2007.)
|
59,950
|
59,950
|
|||||
Shareholders’
equity:
|
|||||||
Common
stock ($.0001 par value); 150,000,000 shares authorized at July
31, 2008
and October 31, 2007; 68,753,256 and 68,085,059 shares issued and
outstanding at July 31, 2008 and October 31, 2007,
respectively.
|
7
|
7
|
|||||
Additional
paid-in capital
|
577,594
|
571,944
|
|||||
Accumulated
deficit
|
(507,802
|
)
|
(437,929
|
)
|
|||
Treasury
stock, Common, at cost (8,981 and 12,282 shares at July 31, 2008
and
October 31, 2007, respectively)
|
(90
|
)
|
(126
|
)
|
|||
Deferred
compensation
|
90
|
126
|
|||||
Total
shareholders’ equity
|
69,799
|
134,022
|
|||||
Total
liabilities and shareholders’ equity
|
$
|
210,367
|
$
|
253,188
|
Three Months Ended
July 31,
|
|||||||
2008
|
2007
|
||||||
Revenues:
|
|||||||
Product
sales and revenues
|
$
|
23,220
|
$
|
7,807
|
|||
Research
and development contracts
|
4,684
|
5,737
|
|||||
Total
revenues
|
27,904
|
13,544
|
|||||
Costs
and expenses:
|
|||||||
Cost
of product sales and revenues
|
39,010
|
14,903
|
|||||
Cost
of research and development contracts
|
4,373
|
4,718
|
|||||
Administrative
and selling expenses
|
4,926
|
4,676
|
|||||
Research
and development expenses
|
5,741
|
6,980
|
|||||
Total
costs and expenses
|
54,050
|
31,277
|
|||||
Loss
from operations
|
(26,146
|
)
|
(17,733
|
)
|
|||
Interest
expense
|
(16
|
)
|
(24
|
)
|
|||
Loss
from equity investments
|
(245
|
)
|
(414
|
)
|
|||
Interest
and other income, net
|
900
|
3,152
|
|||||
Loss
before redeemable minority interest
|
(25,507
|
)
|
(15,019
|
)
|
|||
Redeemable
minority interest
|
(473
|
)
|
(421
|
)
|
|||
Loss
before provision for income taxes
|
(25,980
|
)
|
(15,440
|
)
|
|||
Provision
for income taxes
|
—
|
—
|
|||||
Net
loss
|
(25,980
|
)
|
(15,440
|
)
|
|||
|
|||||||
Preferred
stock dividends
|
(802
|
)
|
(802
|
)
|
|||
Net
loss to common shareholders
|
$
|
(26,782
|
)
|
$
|
(16,242
|
)
|
|
Loss
per share basic and diluted:
|
|||||||
Net
loss per share to common shareholders
|
$
|
(0.39
|
)
|
$
|
(0.24
|
)
|
|
Basic
and diluted weighted average shares outstanding
|
68,703,812
|
67,939,527
|
Nine Months Ended
July 31,
|
|||||||
2008
|
2007
|
||||||
Revenues:
|
|||||||
Product
sales and revenues
|
$
|
59,428
|
$
|
21,567
|
|||
Research
and development contracts
|
15,138
|
10,194
|
|||||
Total
revenues
|
74,566
|
31,761
|
|||||
Costs
and expenses:
|
|||||||
Cost
of product sales and revenues
|
98,207
|
44,679
|
|||||
Cost
of research and development contracts
|
13,644
|
8,758
|
|||||
Administrative
and selling expenses
|
15,536
|
13,866
|
|||||
Research
and development expenses
|
17,157
|
20,489
|
|||||
Total
costs and expenses
|
144,544
|
87,792
|
|||||
Loss
from operations
|
(69,978
|
)
|
(56,031
|
)
|
|||
License
fee income, net
|
—
|
34
|
|||||
Interest
expense
|
(65
|
)
|
(72
|
)
|
|||
Loss
from equity investments
|
(1,295
|
)
|
(1,032
|
)
|
|||
Interest
and other income, net
|
2,849
|
5,654
|
|||||
Loss
before redeemable minority interest
|
(68,489
|
)
|
(51,447
|
)
|
|||
Redeemable
minority interest
|
(1,384
|
)
|
(1,233
|
)
|
|||
Loss
before provision for income taxes
|
(69,873
|
)
|
(52,680
|
)
|
|||
Provision
for income taxes
|
—
|
—
|
|||||
Net
loss
|
(69,873
|
)
|
(52,680
|
)
|
|||
|
|||||||
Preferred
stock dividends
|
(2,406
|
)
|
(2,406
|
)
|
|||
Net
loss to common shareholders
|
$
|
(72,279
|
)
|
$
|
(55,086
|
)
|
|
Loss
per share basic and diluted:
|
|||||||
Net
loss per share to common shareholders
|
$
|
(1.06
|
)
|
$
|
(0.92
|
)
|
|
Basic
and diluted weighted average shares outstanding
|
68,499,395
|
59,967,137
|
Nine Months Ended
July 31,
|
|||||||
2008
|
2007
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(69,873
|
)
|
$
|
(52,680
|
)
|
|
Adjustments
to reconcile net loss to net cash used in
|
|||||||
operating
activities:
|
|||||||
Stock-based
compensation
|
4,231
|
3,939
|
|||||
Loss
in equity investments
|
1,295
|
1,032
|
|||||
Loss
on redeemable minority interest
|
1,384
|
1,233
|
|||||
Interest
receivable on loan to affiliate
|
(125
|
)
|
(23
|
)
|
|||
Asset
impairment
|
179
|
—
|
|||||
(Gain)
Loss on derivative
|
(44
|
)
|
65
|
||||
Depreciation
|
6,574
|
7,004
|
|||||
Amortization
(accretion) of bond premium (discount)
|
347
|
(574
|
)
|
||||
Provision
for doubtful accounts
|
(47
|
)
|
53
|
||||
(Increase)
decrease in operating assets:
|
|||||||
Accounts
receivable
|
(9,670
|
)
|
(812
|
)
|
|||
Inventories
|
2,465
|
(5,847
|
)
|
||||
Other
assets
|
(1,417
|
)
|
(4,981
|
)
|
|||
Increase
(decrease) in operating liabilities:
|
|||||||
Accounts
payable
|
4,903
|
(4,486
|
)
|
||||
Accrued
liabilities
|
1,749
|
2,497
|
|||||
Deferred
revenue and customer deposits
|
12,156
|
10,892
|
|||||
Deferred
license fee income and other
|
600
|
(38
|
)
|
||||
Net
cash used in operating activities
|
(45,293
|
)
|
(42,726
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures
|
(5,651
|
)
|
(3,487
|
)
|
|||
Loan
to affiliate
|
—
|
(2,000
|
)
|
||||
Treasury
notes matured
|
69,600
|
270,609
|
|||||
Treasury
notes purchased
|
(62,784
|
)
|
(237,137
|
)
|
|||
Net
cash provided by investing activities
|
1,165
|
27,985
|
|||||
Cash
flows from financing activities:
|
|||||||
Repayment
of debt
|
(534
|
)
|
(318
|
)
|
|||
Proceeds
from debt
|
2,663
|
354
|
|||||
Payment
of preferred dividends
|
(2,840
|
)
|
(2,840
|
)
|
|||
Net
proceeds from sale of common stock
|
1,746
|
95,457
|
|||||
Common
stock issued for option and stock purchase plans
|
1,016
|
1,941
|
|||||
Net
cash provided by financing activities
|
2,051
|
94,594
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(42,077
|
)
|
79,853
|
||||
Cash
and cash equivalents-beginning of period
|
92,997
|
26,247
|
|||||
Cash
and cash equivalents-end of period
|
$
|
50,920
|
$
|
106,100
|
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
(Losses)
|
Fair
Value
|
|||||||||
At
July 31, 2008
|
|
|
|
|
|||||||||
U.S.
government obligations
|
$
|
53,471
|
$
|
27
|
$
|
(57
|
)
|
$
|
53,441
|
||||
At
October 31, 2007
|
|
|
|
|
|||||||||
U.S.
government obligations
|
$
|
60,634
|
$
|
71
|
$
|
(1
|
)
|
$
|
60,704
|
July 31,
|
October 31,
|
||||||
2008
|
2007
|
||||||
Short-term
investments
|
$
|
26,746
|
$
|
60,634
|
|||
Long-term
investments
|
26,725
|
—
|
|||||
Total
|
$
|
53,471
|
$
|
60,634
|
July 31,
|
October 31,
|
||||||
2008
|
2007
|
||||||
Raw
materials
|
$
|
11,946
|
$
|
8,682
|
|||
Work-in-process
|
15,170
|
20,899
|
|||||
Total
|
$
|
27,116
|
$
|
29,581
|
July 31,
2008
|
October 31,
2007
|
Estimated
Useful Life
|
||||||||
Land
|
$
|
524
|
$
|
524
|
—
|
|||||
Building
and improvements
|
6,609
|
6,454
|
10-26
years
|
|||||||
Machinery,
equipment and software
|
57,174
|
53,449
|
3-8
years
|
|||||||
Furniture
and fixtures
|
2,443
|
2,468
|
10
years
|
|||||||
Equipment
leased to others
|
—
|
2,063
|
3
years
|
|||||||
Power
plants for use under power purchase agreements
|
17,743
|
17,743
|
10
years
|
|||||||
Construction
in progress
|
6,713
|
5,009
|
||||||||
91,206
|
87,710
|
|||||||||
Less,
accumulated depreciation and amortization
|
(52,445
|
)
|
(48,098
|
)
|
||||||
Total
|
$
|
38,761
|
$
|
39,612
|
|
Three Months Ended
July 31,
|
Nine Months Ended
July 31,
|
|||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Cost
of product sales and revenues
|
$
|
251
|
$
|
160
|
$
|
729
|
$
|
539
|
|||||
Cost
of research and development contracts
|
61
|
78
|
201
|
216
|
|||||||||
General
and administrative expense
|
810
|
737
|
2,556
|
2,334
|
|||||||||
Research
and development expense
|
208
|
264
|
701
|
821
|
|||||||||
Total
share-based compensation
|
$
|
1,330
|
$
|
1,239
|
$
|
4,188
|
$
|
3,910
|
Three Months Ended
July 31,
|
Nine Months Ended
July 31,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Expected
life (in years)
|
6.8
|
6.6
|
6.7
|
6.5
|
|||||||||
Risk-free
interest rate
|
3.75
|
4.81
|
%
|
3.22
|
4.55
|
%
|
|||||||
Volatility
|
63.7
|
57.1
|
%
|
64.0
|
61.3
|
%
|
|||||||
Dividend
yield
|
—
|
—
|
—
|
—
|
Number of
options
|
Weighted
average
option price
|
||||||
Outstanding
at October 31, 2007
|
5,325,341
|
$
|
11.11
|
||||
Granted
|
1,272,169
|
8.53
|
|||||
Exercised
|
(316,625
|
)
|
3.08
|
||||
Forfeited/Cancelled
|
(159,616
|
)
|
11.28
|
||||
Outstanding
at July 31, 2008
|
6,121,269
|
$
|
11.01
|
Options Outstanding
|
Options Exercisable
|
||||||||||||||||||||||
Range of exercise
prices
|
Number
outstanding
|
Weighted
average
remaining
contractual
life (years)
|
Weighted
average
exercise
price ($)
|
Number
exercisable
|
Weighted
average
exercise
price ($)
|
||||||||||||||||||
$
|
0.28
|
-
|
$
|
5.10
|
106,000
|
0.7
|
1.63
|
106,000
|
1.63
|
||||||||||||||
$
|
5.11
|
-
|
$
|
9.92
|
3,548,078
|
7.8
|
7.96
|
1,467,596
|
7.65
|
||||||||||||||
$
|
9.93
|
-
|
$
|
14.74
|
1,665,573
|
5.8
|
12.11
|
1,283,545
|
12.60
|
||||||||||||||
$
|
14.75
|
-
|
$
|
19.56
|
310,618
|
2.7
|
16.85
|
310,618
|
16.85
|
||||||||||||||
$
|
19.57
|
-
|
$
|
24.39
|
235,000
|
2.5
|
23.01
|
235,000
|
23.01
|
||||||||||||||
$
|
24.40
|
-
|
$
|
29.21
|
27,000
|
2.5
|
26.15
|
27,000
|
26.15
|
||||||||||||||
$
|
29.22
|
-
|
$
|
34.03
|
165,000
|
2.4
|
29.91
|
165,000
|
29.91
|
||||||||||||||
$
|
34.04
|
-
|
$
|
48.49
|
64,000
|
2.2
|
38.50
|
64,000
|
38.50
|
||||||||||||||
6,121,269
|
6.4
|
11.01
|
3,658,759
|
12.66
|
Number of
Shares
|
||||
Balance
at October 31, 2007
|
308,270
|
|||
Issued
@ $5.67
|
(25,716
|
)
|
||
Issued
@ $7.51
|
(15,337
|
)
|
||
Balance
at July 31, 2008
|
267,217
|
Nine months ended
July 31, 2008
|
||||
Expected
life (in years)
|
.5
|
|||
Risk-free
interest rate
|
2.1
|
%
|
||
Volatility
|
69
|
%
|
||
Dividend
yield
|
—
|
Balance
at October 31, 2007
|
$
|
134,022
|
||
Increase
in additional paid-in-capital for stock-based compensation
|
4,231
|
|||
Increase
in additional paid-in-capital for stock issued under employee benefit
plans
|
2,331
|
|||
Common
stock sales
|
1,494
|
|||
Series
B Preferred dividends
|
(2,406
|
)
|
||
Net
loss
|
(69,873
|
)
|
||
Balance
at July 31, 2008
|
$
|
69,799
|
Three months ended
July 31,
|
Nine months ended
July 31,
|
||||||||||||
Revenues:
|
2008
|
|
2007
|
2008
|
2007
|
||||||||
United
States
|
$
|
19,293
|
$
|
9,429
|
$
|
41,063
|
$
|
21,591
|
|||||
South
Korea
|
7,081
|
1,643
|
30,021
|
*
|
|||||||||
Canada
|
*
|
*
|
*
|
3,562
|
|||||||||
Germany
|
*
|
2,316
|
*
|
4,033
|
Three months ended
July 31,
|
Nine months ended
July 31,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Weighted
average basic common shares
|
68,703,812
|
67,939,527
|
68,499,395
|
59,967,137
|
|||||||||
Effect
of dilutive securities(1)
|
—
|
—
|
—
|
—
|
|||||||||
Weighted
average basic common shares adjusted for diluted calculations
|
68,703,812
|
67,939,527
|
68,499,395
|
59,967,137
|
(1) |
We
computed earnings per share without consideration of potentially
dilutive
instruments because losses incurred would make them antidilutive.
Future
potentially dilutive stock options that were in-the-money at July
31, 2008
and 2007 totaled 1,793,467 and 1,580,233 million,
respectively. Future potentially dilutive stock options that were
not
in-the-money at July 31, 2008 and 2007 totaled 4,327,802 and 3,707,033
million, respectively.
We also have future potentially dilutive warrants issued, which vest
and
expire over time.
As of July 31, 2008, 37,500 warrants were vested with an exercise
price of
$9.89 and we also had 750,000 unvested warrants.
|
Nine Months Ended
July 31,
|
|||||||
2008
|
2007
|
||||||
Cash
paid during the period for:
|
|||||||
Interest
|
$
|
67
|
$
|
72
|
|||
Supplemental
disclosure of non-cash investing and financing activities:
|
|||||||
Accrued
Employee Stock Purchase Plan
|
$
|
146
|
$
|
128
|
|||
Sales
of common stock (1)
|
149
|
—
|
|||||
Accrued
Common Stock Issued for Bonus Incentive
|
1,050
|
942
|
|||||
Impact
on investing activities resulting from the sale of the power plant
used
under a power purchase agreement to Sierra Nevada Brewing
Co.(2)
|
—
|
(3,943
|
)
|
(1) |
Sales
of common stock confirmed during the period and settled subsequent
to July
31, 2008.
|
(2) |
In
December 2006, we completed the sale of the 1 MW power plant that
had been
operating under a power purchase agreement to the Sierra Nevada Brewing
Co. The net book value of the asset of approximately $3.9 million
that was
recorded in property, plant and equipment as of October 31, 2006,
was
recorded in cost of product sales and revenues upon the sale of the
asset.
In addition, this sale resulted in the assumption by the buyer of
certain
of our incentive fund liabilities resulting in a $2.2 million decrease
in
deferred revenue liabilities, which was recorded in cost of product
sales
and revenues.
|
·
|
Ultra-clean
(e.g. virtually zero emissions), quiet
operation
|
·
|
High
fuel efficiency
|
·
|
Reliable,
24/7 baseload power
|
·
|
Ability
to site units locally
|
·
|
Potentially
lower cost power generation
|
·
|
Byproduct
heat ideal for cogeneration (combined heat and power)
applications.
|
·
|
In
April 2008, POSCO Power ordered 25.6 megawatts (“MW”) of MW-class power
plants and fuel cell modules, valued at approximately $70.0 million,
for
delivery in 2009. Initially we will ship complete power plants to
POSCO
Power. In 2009, we will begin to ship fuel cell modules, together
with
complete sets of balance of plant components. POSCON (a POSCO affiliated
company) will do the balance of plant assembly with our technical
support.
In the second half of 2009, we will begin to ship fuel cell modules
only,
and POSCO will be responsible for procurement and manufacturing of
all
balance of plant components.
|
·
|
In
February 2008, CFC Solutions ordered stack components totaling
approximately 0.8 MW.
|
·
|
In
December 2007, The Linde Group (Linde), the world’s largest industrial
gases company, ordered a DFC300 and 3 DFC1500 power plants (3.9 MW).
(Refer to additional discussion below in
Backlog.)
|
·
|
In
December 2007, Eastern Municipal Water District (EMWD) in southern
California ordered three DFC300 power plants (0.75 MW) to provide
power
for its wastewater operations.
|
·
|
In
December 2007, POSCO Power ordered two DFC3000 power plants (4.8
MW).
|
·
|
A
9.0 MW DFC-ERG system will be located at a natural gas letdown station
in
Milford, Conn. The system will generate heat and electricity required
for
the station’s management of the natural gas pipeline resulting in an
electrical efficiency of approximately 60 percent.
|
·
|
Two
projects at Connecticut hospitals, a 4.8 MW DFC power plant for Stamford
Hospital and a 2.4 MW power plant at Waterbury Hospital. The hospitals
will use the byproduct heat generated by our power plants for heating,
air
conditioning, laundries and sterilization, and achieve system efficiencies
of approximately 60 percent.
|
Three Months Ended
July 31, 2008
|
Three Months Ended
July 31, 2007
|
Percentage
Increase /
(Decrease) in
Revenues
|
||||||||||||||
|
Revenues
|
Percent of
Revenues
|
Revenues
|
Percent of
Revenues
|
||||||||||||
Revenues: | ||||||||||||||||
Product sales and revenues
|
$
|
23,220
|
83
|
%
|
$
|
7,807
|
58
|
%
|
197
|
%
|
||||||
Research
and development contracts
|
4,684
|
17
|
%
|
5,737
|
42
|
%
|
(18
|
)%
|
||||||||
Total
|
$
|
27,904
|
100
|
%
|
$
|
13,544
|
100
|
%
|
106
|
%
|
Three Months Ended
July 31, 2008
|
Three Months Ended
July 31, 2007
|
Percentage
Increase /
(Decrease)
in Cost of
Revenues
|
||||||||||||||
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
||||||||||||
Cost of revenues: | ||||||||||||||||
Product sales
and revenues
|
$
|
39,010
|
90
|
%
|
$
|
14,903
|
76
|
%
|
162
|
%
|
||||||
Research
and development contracts
|
4,373
|
10
|
%
|
4,718
|
24
|
%
|
(7
|
)%
|
||||||||
Total
|
$
|
43,383
|
100
|
%
|
$
|
19,621
|
100
|
%
|
121
|
%
|
Nine Months Ended
July 31, 2008
|
Nine Months Ended
July 31, 2007
|
Percentage
|
||||||||||||||
|
Revenues
|
Percent of
Revenues
|
Revenues
|
Percent of
Revenues
|
Increase in
Revenues
|
|||||||||||
Revenues: | ||||||||||||||||
Product
sales and revenues
|
$
|
59,428
|
80
|
%
|
$
|
21,567
|
68
|
%
|
176
|
%
|
||||||
Research
and development contracts
|
15,138
|
20
|
%
|
10,194
|
32
|
%
|
48
|
%
|
||||||||
Total
|
$
|
74,566
|
100
|
%
|
$
|
31,761
|
100
|
%
|
135
|
%
|
Nine Months Ended
July 31, 2008
|
Nine Months Ended
July 31, 2007
|
Percentage
|
||||||||||||||
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
Increase in
Cost of
Revenues
|
|||||||||||
Cost of revenues: | ||||||||||||||||
Product
sales and revenues
|
$
|
98,207
|
88
|
%
|
$
|
44,679
|
84
|
%
|
120
|
%
|
||||||
Research
and development contracts
|
13,644
|
12
|
%
|
8,758
|
16
|
%
|
56
|
%
|
||||||||
Total
|
$
|
111,851
|
100
|
%
|
$
|
53,437
|
100
|
%
|
109
|
%
|
·
|
engineering
improvements;
|
·
|
technology
advances;
|
·
|
supply
chain management;
|
·
|
production
volume; and
|
·
|
manufacturing
process improvements
|
Payments Due by Period
|
||||||||||||||||
|
Total
|
Less
than 1
Year
|
1 – 3
Years
|
3 – 5
Years
|
More
Than
5 Years
|
|||||||||||
Contractual
Obligation:
|
||||||||||||||||
Capital
and operating lease commitments (1)
|
$
|
3,904
|
$
|
1,072
|
$
|
852
|
$
|
897
|
$
|
1,083
|
||||||
Term
loans (principal and interest)
|
3,872
|
722
|
655
|
730
|
1,765
|
|||||||||||
Purchase
commitments(2)
|
53,421
|
51,755
|
1,666
|
—
|
—
|
|||||||||||
Series
I Preferred dividends payable (3)
|
24,296
|
489
|
12,815
|
2,443
|
8,549
|
|||||||||||
Series
B Preferred dividends payable (4)
|
4,854
|
3,206
|
1,648
|
—
|
—
|
|||||||||||
Totals
|
$
|
90,347
|
$
|
57,244
|
$
|
17,636
|
$
|
4,070
|
$
|
11,397
|
(1)
|
Future
minimum lease payments on capital and operating
leases.
|
(2)
|
Purchase
commitments with suppliers for materials supplies, and services incurred
in the normal course of business.
|
(3)
|
Quarterly
dividends of Cdn.$312,500 accrue on the Series 1 preferred shares
(subject
to possible reduction pursuant to the terms of the Series 1 preferred
shares on account of increases in the price of our common stock).
We have
agreed to pay a minimum of Cdn.$500,000 in cash or common stock annually
to Enbridge, Inc., the holder of the Series 1 preferred shares, so
long as
Enbridge holds the shares. Interest accrues on cumulative unpaid
dividends
at a 2.45 percent quarterly rate, compounded quarterly, until payment
thereof. Using an exchange rate of Cdn.$.977 to U.S.$1.00 (exchange
rate
on July 31, 2008), cumulative unpaid dividends and accrued interest
of
approximately $8.2 million on the Series 1 preferred shares were
outstanding as of July 31, 2008. For
the purposes of this disclosure, we have assumed an exchange rate
of
Cdn.$.977 to U.S.$1.00 (exchange rate on July 31, 2008) and that
the
minimum dividend payments would be made through 2010. In 2010, we
would be
required to pay any unpaid and accrued dividends. Subsequent to 2010,
we
would be required to pay annual dividend amounts totaling Cdn.$1.25
million. We have the option of paying these dividends in stock or
cash.
|
(4)
|
Dividends
on Series B Preferred Stock accrue at an annual rate of 5% paid quarterly.
The obligations schedule assumes we will pay preferred dividends
on these
shares through November 20, 2009, at which time the preferred shares
may
be subject to mandatory conversion at the option of the Company.
|
Exhibit No.
|
Description
|
|
31.1
|
CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2
|
CFO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
FUELCELL
ENERGY, INC.
|
||
(Registrant)
|
||
September
5, 2008
|
|
/s/
Joseph G. Mahler
|
Date
|
|
Joseph
G. Mahler
Senior
Vice President, Chief Financial
Officer,
Treasurer and Corporate Secretary
(Principal Financial Officer and Principal Accounting Officer)
|
Exhibit No.
|
Description
|
|
31.1
|
CEO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.2
|
CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|